Delivery Order SPE2DR25D3014-SPE2DR26FP1MS
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $8,240.22 to AmerisourceBergen Drug Corp for the supply of Losartan-HCtz 100-12.5 mg tablets in a 90-day supply. This competitively awarded, firm fixed-price contract was executed on December 8, 2025, with an ultimate completion date of December 9, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was applied to this award. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $2,461.85 to AmerisourceBergen Drug Corp for the supply of Losartan-HCL 100-12.5 mg tablets (90-count) on January 5, 2026, with completion scheduled for January 6, 2026. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a single delivery of this antihypertensive medication to support...
- The Defense Logistics Agency awarded a delivery order valued at $7,260.98 to AmerisourceBergen Drug Corp for the supply of Losartan-HCL 100-12.5 mg tablets in quantities of 90, with an ultimate completion date of December 16, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order represents a continuation of AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 13, 2025, for the supply of Losartan-HCTZ 50-12.5 mg tablets in a 90-day supply at a ceiling value of $8,041.08. This firm fixed-price delivery order, with an ultimate completion date of December 15, 2025, will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a non-competitive, competitively awarded contract with no set-aside designation, leveraging...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Losartan-HCTZ 50-12.5 mg tablets (90-count) at a ceiling value of $13,135.35. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract has an ultimate completion date of December 2, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $7,106.46 to AmerisourceBergen Drug Corp for the supply of Losartan-HCTZ 100-12.5 mg tablets in quantities of 90 units. This competitively awarded, firm fixed-price delivery order was issued on November 24, 2025, with an ultimate completion date of November 25, 2025, and represents a non-set-aside procurement. The contract will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order operates...
- The Defense Logistics Agency awarded a delivery order valued at $90,801.69 to AmerisourceBergen Drug Corp for the supply of Losartan-HCTZ 100-12.5 mg tablets (90-count bottles) on December 30, 2025, with a completion date of December 31, 2025. This firm fixed-price delivery order, which carries no set-aside designation, was competitively awarded and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement within...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 30, 2025, for the supply of Losartan-HCL 100-12.5 mg tablets (90-count) with a ceiling value of $4,915.61. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). The order is scheduled for completion by October 31, 2025, and will be fulfilled from the...
- The Defense Logistics Agency awarded a delivery order valued at $5,776.24 to AmerisourceBergen Drug Corp for the supply of Losartan-HCT 100-25 mg tablets (90-count) on September 23, 2025, with completion expected by September 24, 2025. This competitive, firm fixed-price delivery order was issued without a set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a single transaction under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $12,142.17 delivery order to AmerisourceBergen Drug Corp on December 18, 2025, for the supply of Losartan-HCTZ 50-12.5 mg tablets (90-count) with a completion date of December 19, 2025. The contract utilizes firm fixed price pricing and was competitively awarded without set-aside provisions. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the performance location for this order, leveraging its established position as a critical...
- SPE2DR25D3014Indefinite Delivery Contract
- SPE2DR25D3014-SPE2DR26FP1MSDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $14,627.87 to AmerisourceBergen Drug Corp for the supply of Losartan-HCl 100-12.5 mg tablets in a quantity of 90-day supply. This firm fixed price contract was competitively awarded without set-aside designation and is scheduled for completion by January 6, 2026. The award was issued on January 5, 2026, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle serves as a comprehensive pharmaceutical support mechanism enabling AmerisourceBergen to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs globally. The current delivery order for Losartan-HCl, a generic antihypertensive medication, represents a routine pharmaceutical supply transaction supporting Defense Health Agency and other federal healthcare systems' ongoing medical needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.6k | 1/4/26 |